The genetic changes that underlie an especially lethal type of prostate cancer, called neuroendocrine prostate cancer, have been revealed in a new study at Weill Cornell Medicine. Learning more about what causes this type of cancer could lead to new approaches for treating it.
In a study published April 14 in PLOS One, an international research team including Michèle Belot, professor in the Department of Economics, found that children valued sweet food more after receiving it as a reward.
Ilana Lauren Brito, assistant professor of biomedical engineering at Cornell University, comments on the rise of antibiotic resistant bacteria in the United States.
A universal influenza vaccine developed with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases.
Dr. Rainu Kaushal, chair of the Department of Healthcare Policy and Research at Weill Cornell Medicine, has been elected to the National Academy of Medicine
Cornell researchers are leading a review on the risk of coronavirus transmission through breast milk intake and breastfeeding, to inform WHO guidelines during the pandemic.
A new interdisciplinary study from the College of Veterinary Medicine shows that the protein that lubricates our joints may actually be a signal of impending arthritis in animals and humans.
Renerva, a medical startup developing an injectable gel to speed the healing of damaged nerves and creating a nerve-graft product, has joined Cornell’s McGovern Center.
For the third year in a row, Weill Cornell Medicine has been awarded the Health Professions Higher Education Excellence in Diversity Award by INSIGHT Into Diversity magazine.
